Pacemaker-associated superior vena cava syndrome: Role of contrast echocardiography

Yesim Akin; Kumral Cagli; Riza Sarper Okten; Telat Keles; Zehra Golbasi

doi:10.1111/echo.15342

Pacemaker-associated superior vena cava syndrome: Role of contrast echocardiography

Echocardiography. 2022 Apr;39(4):647-653. doi: 10.1111/echo.15342. Epub 2022 Mar 16.

Authors

Yesim Akin¹, Kumral Cagli², Riza Sarper Okten³, Telat Keles⁴, Zehra Golbasi⁴

Affiliations

¹ Department of Cardiology, Faculty of Medicine, Karabuk University, Karabuk, Turkey.
² Gulhane Faculty of Medicine, Ankara City Hospital, Department of Cardiology, University of Health Sciences, Ankara, Turkey.
³ Gulhane Faculty of Medicine, Ankara City Hospital, Department of Radiology, University of Health Sciences, Ankara, Turkey.
⁴ Faculty of Medicine, Ankara City Hospital, Department of Cardiology, Yildirim Beyazit University, Ankara, Turkey.

PMID: 35297100
DOI: 10.1111/echo.15342

Abstract

Pacemaker-associated superior vena cava (SVC) syndrome is increasingly recognized as a nonmalignant type of SVC syndrome. Computed tomographic (CT) angiography is the first choice of imaging for diagnosis but in some cases there is discrepancy between the clinical findings and CT images. In this report we present the role of contrast study with transesophageal echocardiography in a patient with suspicion of SVC syndrome but inconclusive CT findings.

Keywords: contrast study; echocardiography; superior vena cava.

Publication types

Case Reports

MeSH terms

Echocardiography
Echocardiography, Transesophageal
Humans
Pacemaker, Artificial* / adverse effects
Superior Vena Cava Syndrome* / diagnostic imaging
Superior Vena Cava Syndrome* / etiology
Vena Cava, Superior / diagnostic imaging